MVA-PSA/PAP Prostate Cancer Vaccine

Preferred Label : MVA-PSA/PAP Prostate Cancer Vaccine;

NCIt synonyms : Modified Vaccinia Ankara (Bavarian Nordic) Prostate Cancer Vaccine; MVA-PSA PAP Prostate Cancer Vaccine;

NCIt definition : A cancer vaccine consisting of a recombinant modified vaccinia Ankara (MVA) viral vector encoding genes for prostate specific antigen (PSA) and prostate acid phosphatase (PAP) with potential immunostimulatory and antineoplastic activities. Upon administration, MVA-PSA-PAP prostate cancer vaccine expresses PSA and PAP peptides, which may elicit humoral and cellular immune responses against prostate cancer cells expressing PSA and PAP. Multi-antigen vaccine therapy may be more efficacious than single-antigen therapy vaccine therapy.;

Drug name : MVA-BN-PRO;

NCI Metathesaurus CUI : CL383541;

Details

Origin ID

C74064;

UMLS CUI

C2346920;

Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients